Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
15(8):1467-76
Xcessbio is delighted to present you compound libraries
Drugs in development for Parkinson's disease
PubMed PMID: 21249167
VX-770 Size:2mg solid 15(8):1467-76VX 770, is a drug used to treat cystic fibrosis in people with certain mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, who account for 45% cases of cystic fibrosis, and is included in a combination drug, lumacaftor ivacaftor, which is used to treat people with cystic fibrosis who have the F508del mutation in CFTR. Ivacaftor is a "potentiator" of CFTR, meaning it increases the probability that the defective channel
US$ 166750.00
US$ 65550.00
US$ 264500.00
US$ 215625.00
US$ 1073000.00
US$ 14.00
US$ 28.50
US$ 29.95